SCM
AMPH icon

Sterling Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Sterling Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
9,912
-473
-5% -$9.54K ﹤0.01% 1227
2026
Q1 		$203K Sell
10,385
-6,217
-37% -$152K ﹤0.01% 1168
2025
Q4 		$445K Buy
16,602
+4,935
+42% +$127K 0.01% 993
2025
Q3 		$311K Buy
11,667
+1,450
+14% +$37.4K ﹤0.01% 1179
2025
Q2 		$235K Buy
10,217
+898
+10% +$22.3K ﹤0.01% 1226
2025
Q1 		$270K Hold
9,319
– – ﹤0.01% 1127
2024
Q4 		$346K Hold
9,319
– – ﹤0.01% 1116
2024
Q3 		$452K Buy
+9,319
New +$409K 0.01% 912

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sterling Capital Management's AMPH Position: Q2 2026 in Review

Sterling Capital Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 4.6% in Q2 2026, selling an estimated $9.54K and leaving 9,912 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1227.

Sterling Capital Management first reported a position in AMPH in Q3 2024 and has held it in 8 quarters since. The position peaked at $452K in Q3 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Sterling Capital Management held 9,912 shares of Amphastar Pharmaceuticals worth $200K as of Q2 2026.
  • Sterling Capital Management sold 473 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $9.54K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1227 holding.
  • Sterling Capital Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Amphastar Pharmaceuticals position peaked at $452K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.